NBTIs (iThemba)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameNBTIs (iThemba)
Drug Alias Namenon-fluoroquinolone bacterial type II topoisomerase inhibitors (iThemba)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTopoisomerase II inhibitors
TargetsTopoisomerase II
Therapy Area/IndicationsTuberculosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Africa
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesiThemba Pharmaceuticals Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesiThemba Pharmaceuticals Pty Ltd
Active IndicationsN/A
Inactive IndicationsTuberculosis

Other Information

ATC CodeN/A
Related LinksN/A